Use of ADAM 12 for diagnosis and therapy of preeclampsia
Preeclampsia is a disorder affecting
about 5% of pregnant women. It becomes manifest in the last trimester of pregnancy and is characterized by high blood pressure, protein in the urine, and, sometimes, edema of the face and hands. When left untreated, preeclampsia can lead to severe problems, endangering both mother and fetus. High blood pressure constricts the blood vessels in the uterus that supply the fetus with oxygen and nutrients. Fetal growth is retarded. Preeclampsia can increase the risk of: placental abruption kidney failure cerebral hemorrhage intravascular coagulation lung edema circulatory collapse
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Microscopic basis of a new form of quantum magnetism
Not all magnets are the same. When we think of magnetism, we often think of magnets that stick to a refrigerator’s door. For these types of magnets, the electronic interactions…
An epigenome editing toolkit to dissect the mechanisms of gene regulation
A study from the Hackett group at EMBL Rome led to the development of a powerful epigenetic editing technology, which unlocks the ability to precisely program chromatin modifications. Understanding how…
NASA selects UF mission to better track the Earth’s water and ice
NASA has selected a team of University of Florida aerospace engineers to pursue a groundbreaking $12 million mission aimed at improving the way we track changes in Earth’s structures, such…